NCT07631299
Nebulized AER101 in Pre-op NSCLC
Not Yet Recruiting
EARLY_PHASE1Ages 18+InterventionalTreatmentUniversity of OklahomaInvestigator-initiated
~5 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:AER101
At a glance
Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
PET SUVmax
Measured over 14 days
Conditions
Where it's being run
2 sites across 1 statesOklahoma2
Study leadership
- Matthew Reinersman, MD · PRINCIPAL_INVESTIGATOR · University of Oklahoma
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
18 years or older
Agree to sign consent and follow study requirements
Recently diagnosed with lung adenocarcinoma or squamous cell carcinoma
Primary patients prior to resection
Candidate for surgery (patients are qualified for inclusion if surgery or radiation treatment are agreed to)
Baseline PET/CT imaging performed at Stephenson Cancer Center available and performed within previous 30 days
Exclusion
Recurrent tumor(s)
Nodal or metastatic tumor (multiple lung tumors are acceptable)
Pregnant patients
Patients unable to provide informed consent
Prisoners
What this trial measures
- PET SUVmax14 days
decreased glycolysis